Alkem Laboratories Ltd. Financials: Quarterly Results
Revenue
3507.63
Cr.
PAT
668.32
Cr.
EBITDA
787.86
Cr.
Alkem Laboratories Ltd. Q1FY26 Financial Metrics
| Indicator | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 3371.14 | 3143.75 | 3374.28 | 3414.67 | 3031.82 |
| Total Income From Operations (Cr.) | 3371.14 | 3143.75 | 3374.28 | 3414.67 | 3031.82 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 787.86 | 424.76 | 767.10 | 808.40 | 648.47 |
| P/L Before Exceptional Items & Tax (Cr.) | 758.08 | 396.34 | 731.07 | 780.26 | 619.36 |
| P/L After Tax from Ordinary Activities (Cr.) | 668.32 | 323.01 | 640.79 | 701.96 | 550.24 |
| Net Profit/Loss For the Period (Cr.) | 668.32 | 323.01 | 640.79 | 701.96 | 550.24 |
| Basic EPS | 55.56 | 25.57 | 52.34 | 57.60 | 45.60 |
FAQs
Alkem Laboratories Ltd. announced its quarterly results for Q1 FY2026 on August 12, 2025.
In Q1 FY2026, Alkem Laboratories Ltd. are as follows:
Revenue: ₹3507.63 crore
Net Profit: ₹668.32 crore.
For Q1 FY2026, Alkem Laboratories Ltd. posted ₹3507.63 crore in revenue and ₹668.32 crore in net profit.
Past quarterly results for Alkem Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.